Bessemer Group Inc. Has $74.46 Million Stock Holdings in The Cooper Companies, Inc. $COO

Bessemer Group Inc. decreased its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 32.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 908,434 shares of the medical device company’s stock after selling 433,284 shares during the period. Bessemer Group Inc. owned 0.46% of Cooper Companies worth $74,456,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. JANA Partners Management LP acquired a new stake in Cooper Companies during the third quarter worth approximately $166,917,000. Rakuten Investment Management Inc. bought a new position in Cooper Companies in the third quarter worth approximately $11,341,000. Massachusetts Financial Services Co. MA boosted its holdings in Cooper Companies by 96.9% in the third quarter. Massachusetts Financial Services Co. MA now owns 3,099,750 shares of the medical device company’s stock worth $212,519,000 after acquiring an additional 1,525,693 shares in the last quarter. Alecta Tjanstepension Omsesidigt boosted its holdings in Cooper Companies by 15.8% in the third quarter. Alecta Tjanstepension Omsesidigt now owns 1,563,000 shares of the medical device company’s stock worth $107,112,000 after acquiring an additional 213,500 shares in the last quarter. Finally, DAVENPORT & Co LLC boosted its holdings in Cooper Companies by 1,359.7% in the fourth quarter. DAVENPORT & Co LLC now owns 567,203 shares of the medical device company’s stock worth $46,642,000 after acquiring an additional 528,346 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Stock Down 1.3%

COO stock opened at $59.61 on Friday. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22. The stock’s 50 day moving average is $68.34 and its 200-day moving average is $75.45. The firm has a market capitalization of $11.63 billion, a PE ratio of 29.51, a P/E/G ratio of 1.56 and a beta of 0.89.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same quarter last year, the company earned $0.92 earnings per share. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Sell-side analysts expect that The Cooper Companies, Inc. will post 4.62 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a report on Saturday, February 28th. Rothschild & Co Redburn lowered Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price target on the stock. in a report on Wednesday, March 4th. Needham & Company LLC increased their price target on Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a report on Friday, March 6th. Barclays increased their price target on Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, March 6th. Finally, Citigroup cut their price target on Cooper Companies from $88.00 to $87.00 and set a “neutral” rating on the stock in a report on Friday, March 6th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $90.79.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.